Gu Kong

25.7k total citations
101 papers, 4.2k citations indexed

About

Gu Kong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Gu Kong has authored 101 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 30 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Gu Kong's work include Epigenetics and DNA Methylation (20 papers), Cancer Cells and Metastasis (15 papers) and Cancer-related Molecular Pathways (9 papers). Gu Kong is often cited by papers focused on Epigenetics and DNA Methylation (20 papers), Cancer Cells and Metastasis (15 papers) and Cancer-related Molecular Pathways (9 papers). Gu Kong collaborates with scholars based in South Korea, United States and Japan. Gu Kong's co-authors include Jeong‐Yeon Lee, Mi‐Ock Lee, Young‐Gun Yoo, Heekyoung Chung, Seok Jin Nam, Hee‐Young Won, Young‐Ha Oh, Hee‐Joo Choi, Myeong Hee Moon and Kyung‐Sun Kang and has published in prestigious journals such as Nature, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Gu Kong

100 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gu Kong South Korea 41 2.7k 1.1k 932 387 325 101 4.2k
Jaydutt V. Vadgama United States 41 2.4k 0.9× 1.6k 1.4× 879 0.9× 485 1.3× 455 1.4× 130 4.5k
Da‐Tian Bau Taiwan 34 2.1k 0.8× 691 0.6× 921 1.0× 409 1.1× 251 0.8× 163 3.6k
Brigitte Marian Austria 36 2.3k 0.8× 1.1k 1.0× 664 0.7× 295 0.8× 201 0.6× 111 3.8k
George G. Chen Hong Kong 31 2.2k 0.8× 862 0.8× 1.1k 1.2× 282 0.7× 255 0.8× 119 3.6k
Wen‐Chun Hung Taiwan 45 3.1k 1.2× 1.5k 1.4× 1.2k 1.3× 349 0.9× 337 1.0× 143 5.3k
Satya Narayan United States 33 2.1k 0.8× 906 0.8× 533 0.6× 467 1.2× 301 0.9× 143 3.3k
Margie L. Clapper United States 34 1.9k 0.7× 714 0.7× 577 0.6× 267 0.7× 381 1.2× 95 3.2k
Juan Ángel Fresno Vara Spain 21 2.2k 0.8× 810 0.8× 919 1.0× 318 0.8× 192 0.6× 66 3.3k
Rosa M. Pascale Italy 37 2.5k 0.9× 705 0.7× 934 1.0× 362 0.9× 267 0.8× 112 3.9k
Ziming Dong China 34 2.1k 0.8× 712 0.7× 692 0.7× 269 0.7× 326 1.0× 127 3.3k

Countries citing papers authored by Gu Kong

Since Specialization
Citations

This map shows the geographic impact of Gu Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gu Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gu Kong more than expected).

Fields of papers citing papers by Gu Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gu Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gu Kong. The network helps show where Gu Kong may publish in the future.

Co-authorship network of co-authors of Gu Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Gu Kong. A scholar is included among the top collaborators of Gu Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gu Kong. Gu Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Xiaolin, Fei Cao, Mingxiang Zhang, et al.. (2025). Targeting symbionts by apolipoprotein L proteins modulates gut immunity. Nature. 643(8070). 210–218. 7 indexed citations
2.
Ji, Mi‐Jung, et al.. (2023). Identification of novel class inhibitors of NSD3 methyltransferase showing a unique, bivalent binding mode in the SET domain. Chemical Biology & Drug Design. 102(3). 500–513. 6 indexed citations
3.
Park, Mi Kyung, Hee‐Joo Choi, Young-Un Park, et al.. (2020). NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression. Cancer Research. 81(1). 77–90. 50 indexed citations
4.
Davies, Helen, Sandro Morganella, Colin A. Purdie, et al.. (2017). Whole-Genome Sequencing Reveals Breast Cancers with Mismatch Repair Deficiency. Cancer Research. 77(18). 4755–4762. 76 indexed citations
5.
Choi, Hee‐Joo, Hee‐Young Won, Kyueng‐Whan Min, et al.. (2017). Role of RBP2-Induced ER and IGF1R-ErbB Signaling in Tamoxifen Resistance in Breast Cancer. JNCI Journal of the National Cancer Institute. 110(4). 400–410. 54 indexed citations
6.
Pang, Lili, Xun Gong, Guohao Xie, et al.. (2014). A polymorphism in melanoma differentiation-associated gene 5 may be a risk factor for enterovirus 71 infection. Clinical Microbiology and Infection. 20(10). O711–O717. 22 indexed citations
9.
Shin, Dong‐Hui, Ji‐Hye Park, Hyun‐Jun Kim, et al.. (2010). The in vitro and in vivo anti‐tumor effect of KO‐202125, a sauristolactam derivative, as a novel epidermal growth factor receptor inhibitor in human breast cancer. Cancer Science. 102(3). 597–604. 2 indexed citations
10.
Choi, Kyeong‐Hee, Hyung-Kook Kim, Jun‐hee Kim, et al.. (2010). The p38 MAPK pathway is critical for 5,5′-dibromodiindolylmethane-induced apoptosis to prevent oral squamous carcinoma cells. European Journal of Cancer Prevention. 19(2). 153–159. 12 indexed citations
11.
Shin, Dong‐Hui, Si‐Hyong Jang, Byeong‐Cheol Kang, et al.. (2010). Constitutive overexpression of Id‐1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution. Journal of Cellular Physiology. 226(5). 1340–1352. 9 indexed citations
13.
Kim, Hee-Tae, Gu Kong, David G. DeNardo, et al.. (2006). Identification of Biomarkers Modulated by the Rexinoid LGD1069 (Bexarotene) in Human Breast Cells Using Oligonucleotide Arrays. Cancer Research. 66(24). 12009–12018. 38 indexed citations
14.
Jang, Kiseok, Seung Sam Paik, Heekyoung Chung, Young‐Ha Oh, & Gu Kong. (2006). MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers. Cancer Science. 97(5). 374–379. 91 indexed citations
15.
Lee, Minho, Il Hong, Mingoo Kim, et al.. (2006). Gene expression profiles of murine fatty liver induced by the administration of valproic acid. Toxicology and Applied Pharmacology. 220(1). 45–59. 50 indexed citations
17.
Jung, Byung Hwa, et al.. (2006). Direct determination of nucleosides in the urine of patients with breast cancer using column‐switching liquid chromatography–tandem mass spectrometry. Biomedical Chromatography. 20(11). 1229–1236. 45 indexed citations
18.
Chun, Taehoon, et al.. (2005). The polycomb group gene product Mel‐18 interacts with cyclin D2 and modulates its activity. FEBS Letters. 579(24). 5275–5280. 9 indexed citations
19.
Kim, Seung Hyun & Gu Kong. (2002). Role of Immune-Inflammatory Mechanisms in Alzheimer's Disease and Other Degenerative Diseases. Journal of the Korean Neurological Association. 20(6). 575–584. 2 indexed citations
20.
Jang, Se Jin, et al.. (2001). A novel tumor-associated mucin of gastrointestinal carcinoma. Journal of Cancer Research and Clinical Oncology. 127(9). 551–558. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026